HAUGHEY THOMAS

Insider CIK 1272247 · ANIP Director · PRX President, Director

Track record PRO

XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%

Track record

See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.

Upgrade to Pro · $99/year Already Pro? Log in

Trades across companies

Ticker	Code	Trade	Filed	Shares	Price	Value	Owned after
ANIP ANI PHARMACEUTICALS INC	S Sale	2026-06-08	2026-06-10	2,000	$80.88	$161.8K	38,878	SEC↗
ANIP ANI PHARMACEUTICALS INC	A Award	2026-05-21	2026-06-10	4,357	—	$0	40,878	SEC↗
ANIP ANI PHARMACEUTICALS INC	S Sale	2025-08-12	2025-08-14	19,341	$85.93	$1.66M	36,521	SEC↗
ANIP ANI PHARMACEUTICALS INC	A Award	2025-05-22	2025-05-27	4,336	—	$0	55,862	SEC↗
ANIP ANI PHARMACEUTICALS INC	A Award	2024-05-21	2024-05-23	4,410	—	$0	51,526	SEC↗
ANIP ANI PHARMACEUTICALS INC	A Award	2023-05-23	2023-05-24	6,865	—	$0	47,116	SEC↗
ANIP ANI PHARMACEUTICALS INC	A Award	2022-04-27	2022-04-29	10,049	—	$0	40,251	SEC↗
ANIP ANI PHARMACEUTICALS INC	P Buy	2021-12-06	2021-12-07	2,500	$39.38	$98.5K	30,202	SEC↗
ANIP ANI PHARMACEUTICALS INC	A Award	2021-03-23	2021-03-25	9,292	—	$0	27,702	SEC↗
ANIP ANI PHARMACEUTICALS INC	A Award	2020-04-10	2020-04-14	7,119	—	$0	18,410	SEC↗
ANIP ANI PHARMACEUTICALS INC	P Buy	2020-03-04	2020-03-05	3,000	$45.05	$135.2K	11,291	SEC↗
ANIP ANI PHARMACEUTICALS INC	P Buy	2020-03-03	2020-03-05	2,000	$45.18	$90.4K	8,291	SEC↗
ANIP ANI PHARMACEUTICALS INC	P Buy	2019-05-15	2019-05-15	2,500	$69.30	$173.3K	6,291	SEC↗
ANIP ANI PHARMACEUTICALS INC	A Award deriv	2019-03-28	2019-04-01	2,409	—	$0	2,409	SEC↗
ANIP ANI PHARMACEUTICALS INC	A Award	2019-03-28	2019-04-01	1,991	—	$0	3,791	SEC↗
ANIP ANI PHARMACEUTICALS INC	A Award deriv	2018-06-06	2018-06-08	2,225	—	$0	2,225	SEC↗
ANIP ANI PHARMACEUTICALS INC	A Award	2018-06-06	2018-06-08	1,800	—	$0	1,800	SEC↗
PRX PAR PHARMACEUTICAL COMPANI	D To issuer deriv	2012-09-28	2012-10-02	7,496	$16.38	$122.8K	0	SEC↗
PRX PAR PHARMACEUTICAL COMPANI	D To issuer deriv	2012-09-28	2012-10-02	14,951	$7.86	$117.5K	0	SEC↗
PRX PAR PHARMACEUTICAL COMPANI	D To issuer deriv	2012-09-28	2012-10-02	34,290	$39.01	$1.34M	0	SEC↗
PRX PAR PHARMACEUTICAL COMPANI	D To issuer deriv	2012-09-28	2012-10-02	13,200	$25.73	$339.6K	0	SEC↗
PRX PAR PHARMACEUTICAL COMPANI	D To issuer deriv	2012-09-28	2012-10-02	25,438	$50.00	$1.27M	0	SEC↗
PRX PAR PHARMACEUTICAL COMPANI	D To issuer deriv	2012-09-28	2012-10-02	44,926	$36.94	$1.66M	8,673	SEC↗
PRX PAR PHARMACEUTICAL COMPANI	D To issuer deriv	2012-09-28	2012-10-02	8,673	—	$0	0	SEC↗
PRX PAR PHARMACEUTICAL COMPANI	D To issuer deriv	2012-09-28	2012-10-02	25,262	—	$0	0	SEC↗
PRX PAR PHARMACEUTICAL COMPANI	D To issuer deriv	2012-09-28	2012-10-02	17,789	—	$0	0	SEC↗
PRX PAR PHARMACEUTICAL COMPANI	D To issuer deriv	2012-09-28	2012-10-02	25,438	$50.00	$1.27M	0	SEC↗
PRX PAR PHARMACEUTICAL COMPANI	D To issuer deriv	2012-09-28	2012-10-02	50,875	—	$0	0	SEC↗
PRX PAR PHARMACEUTICAL COMPANI	D To issuer	2012-09-28	2012-10-02	69,648	$50.00	$3.48M	0	SEC↗
PRX PAR PHARMACEUTICAL COMPANI	D To issuer	2012-09-28	2012-10-02	900	$50.00	$45.0K	0	SEC↗
PRX PAR PHARMACEUTICAL COMPANI	F Tax w/h	2012-01-11	2012-01-13	1,017	$35.65	$36.3K	69,648	SEC↗
PRX PAR PHARMACEUTICAL COMPANI	F Tax w/h	2012-01-06	2012-01-09	744	$34.01	$25.3K	70,665	SEC↗
PRX PAR PHARMACEUTICAL COMPANI	A Award deriv	2012-01-05	2012-01-09	25,438	—	$0	25,438	SEC↗
PRX PAR PHARMACEUTICAL COMPANI	A Award deriv	2012-01-05	2012-01-09	25,438	—	$0	25,438	SEC↗
PRX PAR PHARMACEUTICAL COMPANI	A Award deriv	2012-01-05	2012-01-09	50,875	—	$0	50,875	SEC↗
PRX PAR PHARMACEUTICAL COMPANI	F Tax w/h	2012-01-04	2012-01-06	1,057	$32.17	$34.0K	71,409	SEC↗